Ali, A., Torka, P., Wang, Y., Graff, T., Mulvey, E., Zhang, Y., Jun, M., Alshreef, A., Mutebi, A., Wang, A., Tybor, D., Huynh, L., Lax, A., Branchcomb, T., Duh, M. S., Muñoz, J., Moustafa, M. A., Ahmed, N. (2025). Effectiveness of epcoritamab in a heterogeneous population with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) including post-chimeric antigen receptor T-cell therapy (CAR T) patients: Insights from the real-world epcoritamab patient characteristics and outcomes research (Real-EPCOR) study. Blood. https://doi.org/10.1182/blood-2025-8075